Follow
Eva Hurt-camejo
Eva Hurt-camejo
Chief Scientist, R&D BiophaPharmaceuticals, AstraZeneca. Adj.Professor, Karolisnka Institute
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes
E Leinonen, E Hurt-Camejo, O Wiklund, LM Hultén, A Hiukka, ...
Atherosclerosis 166 (2), 387-394, 2003
5192003
Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis
G Camejo, E Hurt-Camejo, O Wiklund, G Bondjers
Atherosclerosis 139 (2), 205-222, 1998
4761998
Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis
R Kleemann, L Verschuren, MJ van Erk, Y Nikolsky, NHP Cnubben, ...
Genome biology 8, 1-16, 2007
2792007
Phospholipase A2 in Vascular Disease
E Hurt-Camejo, G Camejo, H Peilot, K Öörni, P Kovanen
Circulation research 89 (4), 298-304, 2001
2772001
Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.
E Hurt-Camejo, G Camejo, B Rosengren, F Lopez, C Ahlström, G Fager, ...
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 12 (5), 569-583, 1992
2501992
Cellular consequences of the association of apoB lipoproteins with proteoglycans: potential contribution to atherogenesis
E Hurt-Camejo, U Olsson, O Wiklund, G Bondjers, G Camejo
Arteriosclerosis, thrombosis, and vascular biology 17 (6), 1011-1017, 1997
2401997
Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican
AC Jönsson-Rylander, T Nilsson, R Fritsche-Danielson, ...
Arteriosclerosis, thrombosis, and vascular biology 25 (1), 180-185, 2005
2212005
Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.
E Hurt-Camejo, G Camejo, B Rosengren, F Lopez, O Wiklund, G Bondjers
Journal of lipid research 31 (8), 1387-1398, 1990
2191990
Localization of Nonpancreatic Secretory Phospholipase A2 in Normal and Atherosclerotic Arteries: Activity of the Isolated Enzyme on Low-Density Lipoproteins
E Hurt-Camejo, S Andersen, R Standal, B Rosengren, P Sartipy, ...
Arteriosclerosis, thrombosis, and vascular biology 17 (2), 300-309, 1997
2081997
Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells
G Camejo, G Fager, B Rosengren, E Hurt-Camejo, G Bondjers
Journal of Biological Chemistry 268 (19), 14131-14137, 1993
1981993
Phospholipase A2 enzymes and the risk of atherosclerosis
RS Rosenson, E Hurt-Camejo
European heart journal 33 (23), 2899-2909, 2012
1872012
Elevated levels of small, low‐density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of …
E Hurt‐Camejo, S Paredes, L Masana, G Camejo, P Sartipy, B Rosengren, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2001
1862001
Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages 1
G Camejo, C Halberg, A Manschik-Lundin, E Hurt-Camejo, B Rosengren, ...
Journal of lipid research 39 (4), 755-766, 1998
1651998
Lipolysis of LDL by Human Secretory Phospholipase A2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans
JK Hakala, K Öörni, MO Pentikäinen, E Hurt-Camejo, PT Kovanen
Arteriosclerosis, Thrombosis, and Vascular Biology 21 (6), 1053-1058, 2001
1502001
Effects of simvastatin and atorvastatin on inflammation markers in plasma
O Wiklund, L Mattsson‐Hulten, E Hurt‐Camejo, J Oscarsson
Journal of internal medicine 251 (4), 338-347, 2002
1492002
Lysophosphatidylcholine induces the production of IL-1β by human monocytes
Y Liu-Wu, E Hurt-Camejo, O Wiklund
Atherosclerosis 137 (2), 351-357, 1998
1471998
Proteoglycans and lipoproteins in atherosclerosis
G Camejo, E Hurt-Camejo, U Olsson, G Bondjers
Current Opinion in Lipidology 4 (5), 385-391, 1993
1461993
Rupture of the atherosclerotic plaque: does a good animal model exist?
P Cullen, R Baetta, S Bellosta, F Bernini, G Chinetti, A Cignarella, ...
Arteriosclerosis, thrombosis, and vascular biology 23 (4), 535-542, 2003
1452003
Phospholipase A2 modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans
P Sartipy, G Camejo, L Svensson, E Hurt-Camejo
Journal of biological chemistry 274 (36), 25913-25920, 1999
1401999
Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
J Oscarsson, E Hurt-Camejo
Lipids in health and disease 16, 1-13, 2017
1382017
The system can't perform the operation now. Try again later.
Articles 1–20